DNAprint Genomics (DNAG)

[worktoplay]

bag8ger...The only requirement was the licensing of one of the company's classifiers. This is just MO, but I take the language, and the issuance of the shares to mean that due to a change in the business plan they are not planning on licensing individual classifiers as first envisioned.

My current guess, based on what was in the TWST article, is that they will acquire a drug pipeline and offer the tests as part of the prescription process. Their ability to predetermine efficacy and adverse events will enhance the value of the drugs they offer, and will make them the supplier of choice. i.e., do you want to be experimented on at your expense, or would you like to know before you spend your money that what you will be putting into your system will both work as intended and do you no harm.

Later,
W2P